A detailed history of Opal Wealth Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 1,649 shares of JNJ stock, worth $271,788. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,649
Previous 2,335 29.38%
Holding current value
$271,788
Previous $369,000 34.69%
% of portfolio
0.08%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$144.38 - $157.78 $99,044 - $108,237
-686 Reduced 29.38%
1,649 $241,000
Q1 2024

Apr 11, 2024

SELL
$155.22 - $162.74 $224,137 - $234,996
-1,444 Reduced 38.21%
2,335 $369,000
Q4 2023

Jan 19, 2024

SELL
$145.6 - $158.88 $34,798 - $37,972
-239 Reduced 5.95%
3,779 $592,000
Q3 2023

Oct 18, 2023

SELL
$155.75 - $174.48 $76,473 - $85,669
-491 Reduced 10.89%
4,018 $625,000
Q2 2023

Jul 27, 2023

BUY
$154.35 - $166.11 $147,095 - $158,302
953 Added 26.8%
4,509 $746,000
Q1 2023

Apr 19, 2023

BUY
$151.05 - $180.26 $11,328 - $13,519
75 Added 2.15%
3,556 $551,000
Q4 2022

Feb 03, 2023

SELL
$160.2 - $179.79 $2,082 - $2,337
-13 Reduced 0.37%
3,481 $614,000
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $7,098 - $7,898
44 Added 1.28%
3,494 $571,000
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $74,171 - $82,030
441 Added 14.66%
3,450 $612,000
Q1 2022

May 09, 2022

SELL
$158.14 - $179.59 $11,069 - $12,571
-70 Reduced 2.27%
3,009 $533,000
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $198,342 - $220,068
1,272 Added 70.39%
3,079 $527,000
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $97,707 - $108,579
-605 Reduced 25.08%
1,807 $292,000
Q2 2021

Aug 02, 2021

SELL
$159.48 - $171.07 $103,343 - $110,853
-648 Reduced 21.18%
2,412 $397,000
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $77,912 - $86,774
509 Added 19.95%
3,060 $503,000
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $349,767 - $401,476
2,551 New
2,551 $401,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Opal Wealth Advisors, LLC Portfolio

Follow Opal Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opal Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opal Wealth Advisors, LLC with notifications on news.